Navigation Links
Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
Date:5/5/2011

ial," or similar expressions, or by express or implied discussions regarding potential submissions or approvals for new indications or labeling for Afinitor, or regarding the potential timing of any such submissions or approvals, or regarding potential future revenues from Afinitor. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results with Afinitor to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Afinitor will be submitted or approved for any additional indications or labeling in any market. Nor can there be any guarantee that Afinitor will achieve any particular levels of revenue in the future. In particular, management's expectations regarding Afinitor could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; government, industry and general public pricing pressures; competition in general; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date an
'/>"/>
SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin
2. US Supreme Court Denies Certiorari and Thereby Leaves in Place Second Circuit Ruling That Novartis Pharmaceuticals Corporation Must Pay its Sales Representatives Overtime Compensation
3. Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications
4. Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
5. Novartis Phase II LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients
6. Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients
7. Final Approval of Novartis Gender Discrimination Settlement Slated for November 19
8. Study in NEJM Shows Novartis Drug Afinitor® Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis
9. VIDEO from thenewsmarket.com and Novartis: Novartis drug Afinitor® Approved by FDA as First Medication for Children and Adults With a Benign Brain Tumor Associated With Tuberous Sclerosis
10. Novartis to Expand Global Research Headquarters in Cambridge, MA
11. VIDEO From thenewsmarket.com and Novartis: Phase III Data Show That Novartis Meningococcal Vaccine Menveo® Demonstrated Robust Immunogenicity in Infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... July 14, 2014 Decision Resources Group ... positively influence perceptions of emerging drugs for both ... 100 oncologists (50 medical oncologists and 50 hematological ... of managed care organizations (MCOs), reveals that despite ... the majority of payers say this designation will ...
(Date:7/14/2014)... 14, 2014  More than any other generation, Millennials born ... computers -- but their eyes don,t. These mobile devices demand ... and the eye has not evolved to cope with them. ... can do comfortably often results in tired eyes, focusing problems, ... Eye Strain. Now ZEISS has invented a new type of ...
(Date:7/14/2014)... 2014  Diomics, Inc., provider of X-Swab™, a ... United States Patent and Trademark Office has issued ... biologic sample collection materials, devices made from them, ... diagnostics. The primary method of ... of DNA from a number of commercially-available swabs ...
Breaking Medicine Technology:Breakthrough Therapy Designation is Likely to Sway Oncologists' Confidence in An Agent and Encourage Prescribing 2Breakthrough Therapy Designation is Likely to Sway Oncologists' Confidence in An Agent and Encourage Prescribing 3New Eyeglass Lens Helps Our Eyes Keep Up with our Digital Lives 2New Eyeglass Lens Helps Our Eyes Keep Up with our Digital Lives 3Diomics Announces Issuance Of U.S. Patents For Novel Biologic Sample DNA Collection Materials For Use In Forensics And Diagnostics 2
... Article Underscoring Importance of PGD Technique and Method ... fertility experts, who pioneered the development of Preimplantation ... practices and explaining what errors can be made ... edition of Fertility and Sterility, details ...
... Improve Diagnosis for Children with Cornelia deLange Syndrome-PHILADELPHIA, ... studying a rare genetic disease discovered that a ... keeping chromosomes together also plays an important role ... is disrupted in the multisystem genetic disease Cornelia ...
Cached Medicine Technology:Newly Published Article Details How PGS Techniques Directly Effect Successful Pregnancy Outcomes 2In Rare Disorder, a Familiar Protein Disrupts Gene Function 2In Rare Disorder, a Familiar Protein Disrupts Gene Function 3In Rare Disorder, a Familiar Protein Disrupts Gene Function 4
(Date:7/14/2014)... T.E.N., an information technology and security ... nominations will be accepted now through Sept. 12, ... North America Awards. , Awards include the ... executives who have made a positive impact on ... compliance, privacy and information security; and the ISE® ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 The ... reach USD 4,285.1 million by 2020 growing at ... study by Grand View Research, Inc. Steady increase ... for bioinformatics R&D programs designed for sequencing genomes ... of clinical studies in pharmacogenomics and pharmacokinetics for ...
(Date:7/14/2014)... Since 1986, the Sheraton Premiere at Tysons Corner ... skyline and a staple within the community. With ... “Tysons”, the iconic hotel will now be identified as ... becoming its own municipality, the opening of four Metro ... an evolution of great magnitude and the Sheraton Tysons ...
(Date:7/14/2014)... SC (PRWEB) July 14, 2014 Many diet ... a study by the School of Public Health at ... vegetable consumption had a near-zero effect on weight loss. Now ... be combine with some form of portion control ... method of monitoring portions and controlling how much is consumed, ...
(Date:7/14/2014)... “You've probably heard the expression, 'You ... mean?” This question was posed in an article by ... Medical Group’s blog regarding how people should select what ... . , According to the article, individuals who consume ... a high risk of dehydration and consequent negative health ...
Breaking Medicine News(10 mins):Health News:T.E.N. Accepting Nominations for the 2014 Information Security Executive® North America Awards 2Health News:T.E.N. Accepting Nominations for the 2014 Information Security Executive® North America Awards 3Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 2Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 3Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 4Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 5Health News:Global Computational Biology Market by Application (Cellular & Biological Simulation), by Services (In-house, Contract) is Expected to Reach USD 4,285.1 Million by 2020 6Health News:Iconic Tyson’s Corner Hotel Embraces the New “Tysons” Evolution 2Health News:Iconic Tyson’s Corner Hotel Embraces the New “Tysons” Evolution 3Health News:Iconic Tyson’s Corner Hotel Embraces the New “Tysons” Evolution 4Health News:Increase Vegetable Consumption Has Zero Effect on Weight Loss – Portion Control is Recommended by Experts 2Health News:Increase Vegetable Consumption Has Zero Effect on Weight Loss – Portion Control is Recommended by Experts 3Health News:Drink With Your Mental Health in Mind, Advises an Article by Mental Health America Featured by Western Washington Medical Group 2
... Steven Reinberg HealthDay Reporter , SATURDAY, April 2 ... for atherosclerosis, which can increase the risk of a heart ... were associated with about a 5 percent increase in the ... carotid artery, which carries blood to the brain, the researchers ...
... the risk of developing Alzheimer,s has uncovered five new genes ... Professor Julie Williams from Cardiff ... an additional five new genes bringing the total number ... ten. "What we did in this study is ...
... Discovery, the newest journal of the American Association for ... Meeting 2011, held April 2-6, showed how evaluating the ... better target therapy in breast cancer. Researchers ... the level of macrophages and CD8+ T-cells, two key ...
... ORLANDO, Fla. Using new genetic information, scientists have ... longer telomeres and reduced risk of bladder cancer, according ... 2011, held April 2-6, and simultaneously published in Cancer ... Cancer Research. Jian Gu, Ph.D., assistant professor ...
... use has been linked to thicker arteries, possibly contributing to ... of twin veterans. The data is being presented Tuesday, April ... Orleans. Depression can heighten the risk for heart disease, ... is separate and independent from depression itself, says first author ...
... continuing their work on the Biomarker-integrated Approaches of Targeted Therapy ... the BATTLE trial and presented updated results at the ... John Heymach, M.D., Ph.D., associate professor of thoracic, ... MD Anderson Cancer Center, said this update details the "discovery ...
Cached Medicine News:Health News:Study Hints at Link Between Antidepressants and Heart Trouble 2Health News:Study Hints at Link Between Antidepressants and Heart Trouble 3Health News:Understanding Alzheimer’s: Genetic search uncovers five new genes 2Health News:Understanding Alzheimer’s: Genetic search uncovers five new genes 3Health News:Immune system may guide chemotherapy for breast cancer 2Health News:Genetic variation linked to longer telomeres and lower risk of bladder cancer 2Health News:Antidepressants linked to thicker arteries 2Health News:BATTLE researchers identify new biomarkers for EGFR inhibition 2
... an enterprise visibility solution that allows ... effectiveness, and increase patient satisfaction. ... systems and geospatial visual technologies with ... a real time patient care model ...
MONOJECT SUPRA/HONE Blood Collection Needles - Thin Wall...
... are preominantly used for routine blood collection. ... of the needle protective cap simplifies visual ... example, yellow symbolises the needle dimension 20 ... mm) and black 22 G (0.70 mm). ...
ScanGel® Centrifuge...
Medicine Products: